Neil Henderson,Tariq Sethi,Alison Mackinnon,Hakon Leffler,Ulf Nilsson
申请号：
US16531122
公开号：
US20190375776A1
申请日:
2019.08.05
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Provided is a compound of the general formula (I):The compound of formula (I) is suitable for treating pulmonary fibrosis, such as Idiopathic pulmonary fibrosis in a mammal. Also provided is a method for treatment of pulmonary fibrosis, such as Idiopathic pulmonary fibrosis in a human subject having a galectin-3 level indicative of pulmonary fibrosis or exacerbation of symptoms as well as a method for making said compound.
